PAIN TRIGGERS
Short-acting stimulant medications wear off too quickly, causing hard crashes or fading too early in the workday.
SaaS· late-diagnosed adultsPain 7.00/10WTP 5.0/10Market 6.0/10Validation 8.0Confidence 92%Sep 12, 2026
CrashGuard: ADHD Stimulant Timing & Crash Tracker for Adults
Late-diagnosed adults prescribed short-acting stimulant medications experience severe midday crashes and struggle to optimize their dosing schedules without proper personal tracking tools.
analyticshealthmobile-appnon-technical-usersproductivitysubscriptionworkflow
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
Late-diagnosed adults struggle with medication management, specifically dealing with short-acting stimulant crashes and figuring out appropriate dosing schedules.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Recently diagnosed…some questions
ADHD38
Online tools inform me that 30 at once is pretty high and the doses spread out instead of at once.
postRecently diagnosed…some questions
ADHD38
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
late-diagnosed adultsLate Diagnosed A D H D Adults
Adults over 40 navigating newly prescribed stimulant medications who experience severe midday crashes and struggle with dosing schedules.
Context
Find effective medication management strategies and non-medical tools to handle a late-in-life ADHD diagnosis without severe crashes.
Consulting online tools and peer forums to cross-reference doctor-prescribed medication dosages.
Supplementing or timing medication intake carefully around erratic work schedules to avoid crashing on the job.
Current Workarounds
consulting peer forums and online tools to cross-reference doctor dosages
manually timing medication intake around work schedules to prevent crashes
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Current short-acting medication prescriptions result in sharp, uncomfortable crashes after a few hours.
Online medical information creates confusion regarding safe or standard dosing strategies compared to individual psychiatric prescriptions.
OPPORTUNITY & VALUE
Why Now
Multiple mentions of short-acting stimulants wearing off too quickly and causing hard crashes during the workday.
Value Proposition
Purpose-built specifically for managing stimulant crash curves and daily medication timing rather than generic habit tracking.
Product Direction
A dedicated mobile tracking app that logs medication intake, monitors energy levels, and predicts stimulant crash windows based on individual metabolic responses and personal schedules.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$6/moIndividual premium plan
Model
SaaS subscription
WILLINGNESS TO PAY
Users experience severe workplace disruption from medication crashes and actively seek structured solutions to regain control of their workdays, making a low-cost utility tool easy to justify.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Predict stimulant crashes and optimize daily ADHD dosing schedules”
A dedicated mobile tracking app that logs medication intake, monitors energy levels, and predicts stimulant crash windows based on individual metabolic responses and personal schedules.
Core Features
Stimulant half-life and crash prediction timer
Daily energy level and symptom logging
Medication schedule reminder notifications
Weekly Roadmap
1
W1-W2
Core medication logging and half-life calculation engine functional.
- •Build basic medication logging interface
- •Implement pharmacokinetics half-life calculation model
- •Create local data storage schema
2
W3-W4
Crash prediction notifications and energy logging operational.
- •Develop push notification alerts for predicted crash windows
- •Build daily energy and focus level logging form
- •Design basic analytics trend dashboard
3
W5
In-app subscription and beta testing with 10 late-diagnosed adults.
- •Integrate mobile payment gateway for subscription
- •Onboard 10 beta testers from online ADHD communities
- •Fix critical bugs identified during beta feedback
4
W6
App store submission and initial community launch.
- •Submit app to iOS App Store and Google Play
- •Publish launch post in targeted ADHD support communities
- •Track initial user activation and retention metrics
Launch Strategy
Target online communities and support forums for late-diagnosed adults (r/ADHD, r/adhdwomen, and specialized Facebook groups)
RISKS & ASSUMPTIONS
Top Risks
Medical advice liability perception
Users might misinterpret crash predictions as medical dosing advice, creating potential liability and safety concerns.
Low long-term engagement
Once users stabilize their medication dosage with a psychiatrist, they may stop using a daily tracking app.
Data privacy concerns
Users may hesitate to log sensitive prescription medication data into an unproven third-party app.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 8/10 against 2 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
Why this matters for SaaS founders
It sits at the intersection of "analytics", "health", "mobile-app", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "CrashGuard: ADHD Stimulant Timing & Crash Tracker for Adults" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for analytics?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.